Renaissance Technologies’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13,164
| Closed | -$46.6K | – | 3981 |
|
2024
Q3 | $46.6K | Sell |
13,164
-11,700
| -47% | -$41.4K | ﹤0.01% | 3352 |
|
2024
Q2 | $68.9K | Sell |
24,864
-20,200
| -45% | -$56K | ﹤0.01% | 3245 |
|
2024
Q1 | $299K | Buy |
45,064
+17,045
| +61% | +$113K | ﹤0.01% | 3091 |
|
2023
Q4 | $85K | Buy |
28,019
+9,055
| +48% | +$27.5K | ﹤0.01% | 3345 |
|
2023
Q3 | $29K | Buy |
18,964
+3,100
| +20% | +$4.74K | ﹤0.01% | 3478 |
|
2023
Q2 | $28K | Buy |
15,864
+3,200
| +25% | +$5.65K | ﹤0.01% | 3720 |
|
2023
Q1 | $16K | Buy |
12,664
+2,100
| +20% | +$2.65K | ﹤0.01% | 3851 |
|
2022
Q4 | $25K | Buy |
10,564
+1,029
| +11% | +$2.44K | ﹤0.01% | 3931 |
|
2022
Q3 | $39K | Buy |
9,535
+3,775
| +66% | +$15.4K | ﹤0.01% | 3813 |
|
2022
Q2 | $30K | Buy |
5,760
+2,835
| +97% | +$14.8K | ﹤0.01% | 4080 |
|
2022
Q1 | $30K | Sell |
2,925
-20,597
| -88% | -$211K | ﹤0.01% | 3971 |
|
2021
Q4 | $265K | Sell |
23,522
-13,214
| -36% | -$149K | ﹤0.01% | 3398 |
|
2021
Q3 | $749K | Sell |
36,736
-14,820
| -29% | -$302K | ﹤0.01% | 2705 |
|
2021
Q2 | $1.29M | Sell |
51,556
-10,969
| -18% | -$274K | ﹤0.01% | 2532 |
|
2021
Q1 | $1.79M | Buy |
62,525
+30,806
| +97% | +$881K | ﹤0.01% | 2295 |
|
2020
Q4 | $660K | Sell |
31,719
-28,502
| -47% | -$593K | ﹤0.01% | 2705 |
|
2020
Q3 | $1.55M | Sell |
60,221
-8,973
| -13% | -$232K | ﹤0.01% | 2270 |
|
2020
Q2 | $1.63M | Buy |
69,194
+45,335
| +190% | +$1.07M | ﹤0.01% | 2288 |
|
2020
Q1 | $158K | Sell |
23,859
-695
| -3% | -$4.6K | ﹤0.01% | 3143 |
|
2019
Q4 | $281K | Buy |
24,554
+7,542
| +44% | +$86.3K | ﹤0.01% | 3088 |
|
2019
Q3 | $228K | Buy |
17,012
+7,185
| +73% | +$96.3K | ﹤0.01% | 3111 |
|
2019
Q2 | $142K | Buy |
9,827
+2,661
| +37% | +$38.5K | ﹤0.01% | 3357 |
|
2019
Q1 | $279K | Sell |
7,166
-2,883
| -29% | -$112K | ﹤0.01% | 3115 |
|
2018
Q4 | $169K | Buy |
10,049
+7,562
| +304% | +$127K | ﹤0.01% | 3163 |
|
2018
Q3 | $137K | Buy |
+2,487
| New | +$137K | ﹤0.01% | 3211 |
|